Connor, Clark & Lunn Investment Management (CC&L)’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $17M | Buy |
76,988
+75,376
| +4,676% | +$20.9M | 0.03% | 405 |
|
|
2026
Q1 | $476K | Buy |
1,612
+160
| +11% | +$47.5K | ﹤0.01% | 1321 |
|
|
2025
Q4 | $397K | Buy |
+1,452
| New | +$395K | ﹤0.01% | 1350 |
|
|
2025
Q3 | – | Sell |
-4,588
| Closed | -$1.26M | – | 1524 |
|
|
2025
Q2 | $1.26M | Buy |
+4,588
| New | +$1.25M | ﹤0.01% | 984 |
|
|
2024
Q4 | – | Sell |
-93,444
| Closed | -$20.6M | – | 1429 |
|
|
2024
Q3 | $20.6M | Buy |
93,444
+3,721
| +4% | +$770K | 0.1% | 164 |
|
|
2024
Q2 | $17.6M | Buy |
89,723
+85,713
| +2,137% | +$17.7M | 0.07% | 197 |
|
|
2024
Q1 | $863K | Buy |
+4,010
| New | +$842K | ﹤0.01% | 925 |
|
|
2023
Q4 | – | Sell |
-73,338
| Closed | -$14.7M | – | 1406 |
|
|
2023
Q3 | $14.7M | Sell |
73,338
-10,722
| -13% | -$2.13M | 0.08% | 202 |
|
|
2023
Q2 | $15.6M | Buy |
+84,060
| New | +$15.5M | 0.08% | 188 |
|
|
2023
Q1 | – | Sell |
-68,127
| Closed | -$11.5M | – | 1270 |
|
|
2022
Q4 | $11.5M | Sell |
68,127
-62,816
| -48% | -$10.9M | 0.07% | 208 |
|
|
2022
Q3 | $23.2M | Sell |
130,943
-29,926
| -19% | -$5.91M | 0.15% | 108 |
|
|
2022
Q2 | $32.9M | Sell |
160,869
-89,185
| -36% | -$18.9M | 0.2% | 85 |
|
|
2022
Q1 | $59.5M | Buy |
250,054
+116,948
| +88% | +$27.5M | 0.29% | 60 |
|
|
2021
Q4 | $30.4M | Buy |
133,106
+16,250
| +14% | +$3.58M | 0.15% | 125 |
|
|
2021
Q3 | $22.6M | Buy |
116,856
+111,228
| +1,976% | +$22.5M | 0.12% | 144 |
|
|
2021
Q2 | $1.2M | Buy |
+5,628
| New | +$1.19M | 0.01% | 645 |
|
|
2020
Q3 | – | Sell |
-131,376
| Closed | -$21.4M | – | 953 |
|
|
2020
Q2 | $21.4M | Sell |
131,376
-1,883
| -1% | -$338K | 0.15% | 121 |
|
|
2020
Q1 | $23M | Buy |
+133,259
| New | +$26.5M | 0.21% | 93 |
|
|
2019
Q2 | – | Sell |
-11,925
| Closed | -$1.96M | – | 1000 |
|
|
2019
Q1 | $1.96M | Buy |
+11,925
| New | +$2.11M | 0.01% | 413 |
|
|
2018
Q4 | – | Sell |
-2,925
| Closed | -$498K | – | 952 |
|
|
2018
Q3 | $498K | Sell |
2,925
-42,375
| -94% | -$7.13M | ﹤0.01% | 700 |
|
|
2018
Q2 | $7.43M | Buy |
+45,300
| New | +$7.4M | 0.04% | 250 |
|
|
2016
Q4 | – | Sell |
-15,000
| Closed | -$1.57M | – | 900 |
|
|
2016
Q3 | $1.57M | Buy |
+15,000
| New | +$1.57M | 0.01% | 405 |
|
|
2014
Q2 | – | Sell |
-7,589
| Closed | -$620K | – | 543 |
|
|
2014
Q1 | $620K | Sell |
7,589
-3,300
| -30% | -$249K | ﹤0.01% | 452 |
|
|
2013
Q4 | $908K | Buy |
10,889
+1,289
| +13% | +$101K | 0.01% | 387 |
|
|
2013
Q3 | $729K | Buy |
+9,600
| New | +$707K | 0.01% | 305 |
|
Other funds holding CME
Connor, Clark & Lunn Investment Management (CC&L)'s CME Position: Q2 2026 in Review
Connor, Clark & Lunn Investment Management (CC&L) increased its CME Group (CME) stake by 4,676% in Q2 2026, buying an estimated $20.9M and bringing the position to 76,988 shares worth $17M. The position accounts for 0.03% of the portfolio, ranked #405.
Connor, Clark & Lunn Investment Management (CC&L) first reported a position in CME in Q3 2013 and has held it in 25 quarters since. The position peaked at $59.5M in Q1 2022. 1,698 funds tracked by Wall St. Rank hold CME as of Q2 2026.
- Connor, Clark & Lunn Investment Management (CC&L) held 76,988 shares of CME Group worth $17M as of Q2 2026.
- Connor, Clark & Lunn Investment Management (CC&L) bought 75,376 CME Group shares in Q2 2026, an estimated $20.9M.
- CME Group made up 0.03% of Connor, Clark & Lunn Investment Management (CC&L)'s portfolio in Q2 2026, its #405 holding.
- Connor, Clark & Lunn Investment Management (CC&L) first reported a position in CME Group in Q3 2013 and has held it in 25 quarters since.
- Connor, Clark & Lunn Investment Management (CC&L)'s CME Group position peaked at $59.5M in Q1 2022.
- 1,698 funds tracked by Wall St. Rank held CME Group as of Q2 2026.
Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q2 2026, filed 13 Aug 2026.